AAD 2026 at a glance
AAD 2026 will highlight emerging dermatology trends across immunodermatology, psoriasis, skin oncology, rare skin diseases and AI, with clinical trial developments and digital technologies shaping treatment differentiation, patient care and competitive positioning.
📅 Build your schedule around the topics that matter most.
📥 Download the AAD 2026_Preview_by_LucidQuest
AAD 2026: Key Developments in Dermatology Treatment
Atopic Dermatitis, Eczema, Urticaria and Pruritus
REMIX-1/2, TRACE, ARCADIA, COAST 1/2, SHORE, RADIANT-AD and APEX are set to define durability and broader symptom control.
These developments will help clarify how emerging treatment approaches compete on sustained efficacy and management of symptoms across inflammatory skin conditions.
Psoriasis, Hidradenitis Suppurativa, Vitiligo and Lupus
ICONIC-LEAD, ONWARD 1/2, LATITUDE-PsO-3001/3002, STOP-HS1/2, SUNSHINE/SUNRISE and Viti-Up highlight trial maturity and label expansion.
The evolving evidence may influence treatment positioning and competitive differentiation across immune-mediated dermatologic diseases.
Alopecia Areata, Acne, Pigmentation and Aesthetic Dermatology
THRIVE-AA1/2 and ALLEGRO are expected to lead alopecia areata momentum, while acne, melasma and injectables emphasize refinement.
These developments reflect continued innovation across hair disorders, pigmentation and aesthetic dermatology.
Skin Cancer: Melanoma, Carcinoma and Oncologic Diagnostics
INTASYL PH-762, selective lymphadenectomy follow-up and chemoprevention data are set to shape melanoma and carcinoma discussions.
The findings may inform clinical decision-making and emerging approaches to skin cancer management.
Rare Skin Diseases and Immune-Mediated Dermatoses
PIONEER, INSPIRE, infantile hemangioma Phase 3 data and blistering disease studies highlight unmet need and specialty innovation.
These developments emphasize the importance of clinical evidence generation in dermatologic conditions with limited treatment options.
Dermatology Practice: Patient Access, Diagnostics and Education
SkinTracker, Patient Finder, reflectance confocal microscopy and global access studies show evolving workflows, literacy and equity priorities.
These developments highlight how clinical practice and patient access considerations may influence the adoption of dermatology innovations.
Artificial Intelligence and Machine Learning at AAD 2026
AI in Dermatology: Skin Cancer Diagnosis and Clinical Imaging
AI and machine learning content will center on diagnosis across skin cancer, dermoscopy, dermatopathology, nail disease and inflammatory dermatoses.
These applications highlight the expanding role of AI-assisted diagnostic assessment across dermatology.
AI Equity: Skin Tone Representation and Diagnostic Generalizability
Skin tone, sex representation, Fitzpatrick V–VI performance and darker phototypes remain central analytical concerns.
Evaluating model performance across diverse patient populations will be important for assessing clinical reliability and equitable implementation.
AI for Psoriasis: Image Analysis and Disease Severity Monitoring
Remote severity assessment, lesion segmentation and visualization signal progress from detection toward monitoring and tracking.
These developments may support more consistent assessment of psoriasis severity and disease progression.
Generative AI in Dermatology: Clinical Workflows and Patient Communication
GPT-4, GPT-4o, translation tools, ambient scribing and education platforms position generative AI as a communication enabler.
Their practical value will depend on reliable integration into clinical and educational workflows.
AI Adoption in Dermatology: Patient Trust and Clinical Governance
Patient acceptance, coverage decisions and residency education show implementation depends on trust, governance and workforce readiness.
These factors may influence how quickly AI-enabled technologies become part of routine dermatology practice.
AI in Wound Care: Healing Prediction and Chronic Disease Monitoring
Area assessment, tissue composition analysis and healing prediction broaden AI into longitudinal dermatology care.
These applications highlight opportunities for AI-supported monitoring beyond initial diagnosis.
Download the AAD 2026 Preview Report
Download LucidQuest’s AAD 2026 preview report and planner for insights into emerging dermatology treatments, clinical developments and AI applications.
📅 Build your schedule around the sessions that matter most.
📥 Download the AAD 2026_Preview_by_LucidQuest
Contact us for end-to-end conference coverage.
